China Aoxing Pharmaceutical Company (中国奥星药业), which specializes in the strictly regulated sector of narcotic and pain medications, has submitted its application for SFDA approval of Codeine Phosphate, an oral solution for the treatment of acute moderate to severe cough. China Aoxing expects to launch this product in China in 2010, assuming the regulatory review goes well. More details...

Stock Symbol: (OTCBB: CAXG)